Commentary · 29 Aug 2025
Review articlePublished 6 Dec 2017
Applying precision medicine approach to metastatic castration-resistant prostate cancer: urgent education need on genomic oncology
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Metastatic castration-resistant prostate cancer (mCRPC) remains a therapeutic challenge. As a result of advances in genomic sequencing technology, “next-generation sequencing” (NGS) is increasingly incorporated into clinical trials and routine oncology clinical practice. Molecular profiling of mCRPC can be a valuable way of defining molecular alterations that might contribute to optimal treatments while reduce risk of adverse effects. To effectively apply cutting edge research to daily patient care, oncologists must grasp the fundamentals of genomic oncology, molecular testing and interpretation. There is an urgent need for health professional education to allow implementation of these novel precision medicine tools.
Keywords
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Molecular Oncology Research.
Opinion · 29 Aug 2025
Targeting DNA repair mechanisms: A frontier in molecular oncology research
Rapid communication · 29 Aug 2025
Unlocking the future of cancer care: The role of molecular biomarkers in molecular oncology research
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Molecular Oncology Research
- SubjectOncology & Cancer
- SubjectGenetics & Molecular Biology
- BylineArticles whose byline prints “Jue Wang”
